Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL)

CAPS Rating: 2 out of 5

A specialty biopharmaceutical company with a focus on developing and marketing products to urologists, endocrinologists, orthopedists and select primary care physicians.

Recs

0
Player Avatar bernies1 (< 20) Submitted: 3/24/2008 8:18:56 PM : Outperform Start Price: $26.47 AUXL Score: -28.80

good stock

Featured Broker Partners


Advertisement